|
Volumn 75, Issue 5, 2000, Pages 2163-2171
|
Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity
|
Author keywords
3 Nitropropionic acid; Huntington's disease; Lesion; Metabolic compromise; Striatum; Transgenic mouse
|
Indexed keywords
3 NITROPROPIONIC ACID;
KAINIC ACID;
QUISQUALIC ACID;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN PROTECTION;
CONTROLLED STUDY;
GENE MUTATION;
GENETIC SUSCEPTIBILITY;
HUNTINGTON CHOREA;
LONG TERM EXPOSURE;
METABOLIC DISORDER;
MOUSE;
NEOSTRIATUM;
NERVE CELL LESION;
NEUROTOXICITY;
NONHUMAN;
ONSET AGE;
PHENOTYPE;
PRIORITY JOURNAL;
STRIATE CORTEX;
TRANSGENIC MOUSE;
AGING;
ANIMAL;
BEHAVIOR, ANIMAL;
BODY WEIGHT;
CORPUS STRIATUM;
CROSSES, GENETIC;
DIABETES MELLITUS;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE;
HUNTINGTON DISEASE;
INJECTIONS, SUBCUTANEOUS;
MICE;
MICE, INBRED C57BL;
MICE, INBRED CBA;
MICE, TRANSGENIC;
MUTATION;
PROPIONIC ACIDS;
SUCCINATE DEHYDROGENASE;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0033784437
PISSN: 00223042
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1471-4159.2000.0752163.x Document Type: Article |
Times cited : (46)
|
References (34)
|